Open AccessOutcomes of Chemotherapy for Microsatellite Instable–High Metastatic Colorectal Cancers
Author(s) -
Katerina Shulman,
Ofra BarnettGriness,
Vered Friedman,
Joel K. Greenson,
Stephen B. Gruber,
Flavio Lejbkowicz,
Gad Rennert
Publication year - 2018
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.17.00253
Subject(s) - chemotherapy , medicine , colorectal cancer , oncology , microsatellite instability , microsatellite , cancer , biology , genetics , gene , allele
Microsatellite instable-high (MSI-H) colorectal cancers (CRCs) are known to carry better survival in the local disease stage even without treatment. The influence of types of treatment on survival of MSI-H metastatic CRCs (mCRCs) is still unclear and is evaluated in this study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom